Synaptrix Labs Secures $10 Million in Funding to Revolutionize Assistive Technologies for Paralyzed Individuals

We are thrilled to announce that Synaptrix Labs has successfully raised $10 million in our latest funding round, a significant milestone in our mission to enhance the independence of individuals living with paralysis. At Synaptrix, we are at the forefront of accessible technologies, designing innovative solutions that empower those affected by conditions such as ALS, spinal cord injuries, multiple sclerosis, strokes, and other neurodegenerative disorders. Central to our vision is Neuralis, our flagship product — a non-invasive, EEG-based neural interface that enables paralyzed individuals to control their wheelchairs using only their brain activity and eye movements. This groundbreaking technology interprets signals from the visual cortex, facilitating intuitive and effortless navigation, and importantly, it offers a cost-effective alternative to existing assistive technologies which often come with prohibitive price tags and complexity. With this infusion of capital, we plan to accelerate our research and development efforts, enhance our technology, and expand our outreach to ensure that our solutions reach those who need them most. By prioritizing autonomy and control, we strive to improve the quality of life for individuals facing physical limitations, reintegrating them into society with newfound independence. This funding will not only allow us to refine Neuralis but also to advance our ongoing commitment to pioneering assistive technologies that make a real difference in people's lives. We are deeply grateful to our investors for their support and belief in our vision, as we take this crucial step forward on our journey to empower thousands of individuals and transform the landscape of assistive technology.